BackBioNexus Gene Lab Overview

BioNexus Gene Lab Net Tangible Assets

Track BioNexus Gene Lab's net tangible assets ($7.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$7.78M
3.41% YoYΔ $256405.00 vs prior year quarter

Peer trimmed avg / median

Loading

BioNexus Gene Lab Net Tangible Assets History

Loading

BioNexus Gene Lab vs. peers: Net Tangible Assets Comparison

Loading

BioNexus Gene Lab Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

BioNexus Gene Lab (BGLC) FAQ

BioNexus Gene Lab (BGLC) currently reports a net tangible assets of $7.8M as of June 2026. That compares with $7.5M in the prior-year period — up 3.4% year over year. Use the charts on this page to explore BioNexus Gene Lab's net tangible assets history and peer comparisons.

BioNexus Gene Lab's net tangible assets increased from $7.5M to $7.8M — a 3.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioNexus Gene Lab reported $7.8M in net tangible assets as of June 2026. That compares with $7.5M in the prior-year period — up 3.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $7.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioNexus Gene Lab, and consider following BGLC for alerts when major investors trade the stock.